(Q43572619)

English

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

24 November 2017

1 reference

based on heuristic

inferred from title

Catherine M Bollard

1

object named as

Catherine M Bollard

1 reference

Europe PubMed Central

24 November 2017

Cliona M Rooney

6

object named as

Cliona M Rooney

1 reference

Europe PubMed Central

24 November 2017

7

object named as

Helen E Heslop

1 reference

Europe PubMed Central

24 November 2017

3

object named as

M Helen Huls

1 reference

Europe PubMed Central

24 November 2017

Stephen Gottschalk

2

object named as

Stephen Gottschalk

1 reference

Europe PubMed Central

24 November 2017

Jeffrey J Molldrem

4

object named as

Jeffrey Molldrem

1 reference

Europe PubMed Central

24 November 2017

author name string

Donna Przepiorka

5

1 reference

Europe PubMed Central

24 November 2017

publication date

1 May 2006

1 reference

Europe PubMed Central

24 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

24 November 2017

47

1 reference

Europe PubMed Central

24 November 2017

837-842

1 reference

Europe PubMed Central

24 November 2017

5

1 reference

Europe PubMed Central

24 November 2017

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190600604724

21 January 2018

Identifiers

10.1080/10428190600604724

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43572619&oldid=2101208088"